CompletedNot Applicable

Adaptive Servo-ventilation Monitoring Study

Germany40 participantsStarted 2014-05

Plain-language summary

Sleep disordered breathing is very common in patients with chronic heart failure with reported prevalence rates of 50-75%. Adaptive Servo-Ventilation (ASV) can be used to treat sleep apnea in these patients. This is an observational study to document changes in respiratory parameters in HF patients using ASV for a period of 12 months.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: More than 18 years old Chronic heart failure (at least 12 weeks since diagnosis) according to the currently applicable guidelines NYHA Class III or IV at the time of inclusion with at least one hospitalization for heart failure in the last 12 months Moderate to severe sleep apnea (AHI ≥ 15/hour). Already using or willing to use ASV-therapy and able to tolerate the mask treatment Exclusion Criteria: Planned or scheduled heart valve interventions and/or CABG Untreated or therapy refractory Restless Leg Syndrome Patients for whom the use of positive airway pressure therapy may be contra-indicated because of symptomatic hypotension or significant intravascular volume depletion or pneumothorax or pneumomediastinum Pregnancy

What they're measuring

Correlation of hypoxemia, as measured by overnight pulse oximetery, with worsening heart failure

Timeframe: 12 months

Trial details

NCT IDNCT02133859

SponsorResMed

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2015-07

View on ClinicalTrials.gov More Chronic Heart Failure trials